CROI 2017 Program and Information

Program and Agenda

511 RECENCY STAGING OF HIV INFECTIONS THROUGH ROUTINE DIAGNOSTIC TESTING Eduard Grebe 1 , Alex Welte 1 , Jake Hall 2 , Michael P. Busch 3 , Shelley Facente 4 , Sheila Keating 2 , Kara Marson 4 , Christopher D. Pilcher 4 , Gary Murphy 2 , for the CEPHIA 1 Stellenbosch Univ, Stellenbosch, South Africa, 2 Pub Hlth England, London, UK, 3 Blood Systems Rsr Inst, San Francisco, CA, USA, 4 Univ of California San Francisco, San Francisco, USA 512 DEVELOPMENT OF A HIGH-THROUGHPUTMULTIPLEX ASSAY FOR MEASURING HIV INCIDENCE Martin Stengelin 1 , Daisy Roy 1 , Sudeep Kumar 1 , Kara Marson 2 , Steven G. Deeks 2 , Gary Murphy 3 , Michael P. Busch 4 , Christopher D. Pilcher 2 1 Meso Scale Diagnostics, LLC, Rockville, MD, USA, 2 Univ of California San Francisco, San Francisco, CA, USA, 3 Pub Hlth England, London, UK, 4 Blood Systems Rsr Inst, San Francisco, CA, USA 513 IDENTIFYING RECENT HIV INFECTIONS: AN INDIVIDUALIZED ASSESSMENT OF RISK Jaythoon Hassan 1 , Joanne Moran 1 , Kate O’Donnell 2 , Gary Murphy 3 , Derval Igoe 2 , Cillian De Gascun 1 , for the Monitoring Recently Acquired HIV Infection Group 1 Univ Coll Dublin, Dublin, Ireland, 2 Hlth Protection Surveillance Cntr, Dublin, Ireland, 3 Pub Hlth England, London, UK 514 THE HIV GENOMIC INCIDENCE ASSAYMEETS FRR ANDMDRI PERFORMANCE STANDARDS Sung Yong Park 1 , Tanzy Love 2 , Kathryn Anastos 3 , Jack DeHovitz 4 , Chenglong Liu 5 , Kord Kober 6 , Mardge Cohen 7 , Wendy Mack 1 , Elizabeth T. Golub 8 , Ha Youn Lee 1 1 Univ Southern California, Los Angeles, CA, USA, 2 Univ of Rochester, Rochester, NY, USA, 3 Albert Einstein Coll of Med, Bronx, NY, USA, 4 SUNY Downstate Med Cntr, Brooklyn, NY, USA, 5 Georgetown Univ, Washington, DC, USA, 6 Univ of California San Francisco, San Francisco, CA, USA, 7 Stroger Hosp, Chicago, IL, USA, 8 Johns Hopkins Univ, Baltimore, MD, USA Poster P-L1 HCV TRANSMISSION: THE CASCADE IS NOT RUNNING DRY Poster Hall - 4 EF 2:30 PM - 4:00 PM 515 DURATION OF ACUTE HEPATITIS C INFECTION AND IMPLICATIONS FOR INCIDENCE ESTIMATION Eshan Patel 1 , Anna Eisenberg 2 , Jeffrey Quinn 1 , Thomas C. Quinn 3 , Aaron Tobian 1 , Oliver Laeyendecker 2 1 Johns Hopkins Univ, Baltimore, MD, USA, 2 NIAID, Baltimore, MD, USA, 3 NIAID, Bethesda, MD, USA 516 HEPATITIS C VIRUS GENOTYPE AND IG-G AVIDITY RESPONSE DURING RECENT INFECTION Veronica Bruce 1 , Eshan Patel 2 , Andrea Cox 2 , Shruti H. Mehta 2 , Denali Boon 2 , Jacob Konikoff 2 , David Thomas 2 , Thomas C. Quinn 3 , Kimberly Page 1 , Oliver Laeyendecker 3 1 Univ of NewMexico, Albuquerque, NM, USA, 2 The Johns Hopkins Univ, Baltimore, MD, USA, 3 NIAID, Bethesda, MD, USA 517 IDENTIFICATION OF RISK FACTORS FOR HEPATITIS-C TESTING IN NON-BIRTH COHORT PATIENTS Amanda E. Smart 1 , Alexander Geboy 2 , Peter Basch 2 , Whitney Nichols 2 , Alexander Zeymo 2 , Idene Perez 2 , Maria Hafeez 2 , Ilan Fleisher 2 , Stephen Fernandez 2 , Dawn Fishbein 2 1 Georgetown Univ, Washington, DC, USA 2 MedStar Hlth Rsr Inst, Hyattsville, MD, USA

Poster Sessions • Tuesday

CROI 2017 92